Phase 4 trials for Covaxin to be conducted by Bharat Biotech to confirm real effectiveness
All data derived from the phase 3 trials of Covaxin will be submitted to the Central Drugs Standard Control Organization…
All data derived from the phase 3 trials of Covaxin will be submitted to the Central Drugs Standard Control Organization…
Ocugen Inc has declared a payment of USD 15 million upfront to Bharat Biotech. Earlier on June 3, Bharat Biotech…
After US market, Bharat Biotech targets for Covaxin sale in Canada by collaborating with Ocugen . The companies are extending…
Prime Minister Narendra Modi on Monday took his first dose of the COVID-19 vaccine at AIIMS, Delhi. He was given…
Bharat Biotech is likely to begin Covaxin trial on children by early March 2021. Phase 1 trials will be conducted…
The DCGI has permitted EUO of both Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin for immunisation against Covid-19 in India. On…
According to Sai D Prasad, President, Quality Operations at Bharat Biotech, ‘Covaxin’ will be at least 60 percent effective and…